References
- 1. Helin, H.J., Korpela, M.M., Mustonen, J.T. & Pasternack, A.I. (1995). Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum, 38(2), 242-247..10.1002/art.1780380213
- 2. Karie, S., Gandjbakhch, F., Janus, N., Launay-Vacher, V., Rozenberg, S., Mai Ba, C.U., Bourgeois, P. & Deray, G. (2008). Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Rheumatology (Oxford), 47(3), 350-354. doi: 10.1093/rheumatology/kem370.10.1093/rheumatology/kem370
- 3. Hall, C.L., Jawad, S., Harrison, P.R., MacKenzie, J.C., Bacon, P.A., Klouda, P.T. & MacIver, A.G. (1988). Natural course of penicillamine nephropathy: a long term study of 33 patients. Br Med J (Clin Res Ed), 296(6629), 1083-1086..
- 4. Whelton, A. (1999). Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med, 106(5B), 13S-24S.10.1016/S0002-9343(99)00113-8
- 5. 5 Laakso, M., Mutru, O., Isomaki, H. & Koota, K. (1986). Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis. Ann Rheum Dis, 45(8), 663-667.10.1136/ard.45.8.66310019643740996
- 6. Sihvonen, S., Korpela, M., Mustonen, J., Laippala, P. & Pasternack, A. (2004). Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract, 96(4), c107-114. doi: 10.1159/00007737210.1159/00007737215122064
- 7. van Sijl, A.M., van den Oever, I.A., Peters, M.J., Boers, M., Dijkmans, B.A., van Halm, V.P., Smulders, Y.M., Voskuyl, A.E. & Nurmohamed, M.T. (2012). Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRE Study. Ann Rheum Dis, 71(3), 341-344. doi: 10.1136/annrheumdis-2011-20005110.1136/annrheumdis-2011-20005121953344
- 8. Calculate eGFR using the CKD-EPI formula. (2015). from https://qxmd.com/calculate/egfr-using-ckd-epi
- 9. Sihvonen, S., Korpela, M., Mustonen, J., Laippala, P. & Pasternack, A. (2004). Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract, 96(4), c107-114. doi: 10.1159/00007737210.1159/000077372
- 10. Haroon, M., Adeeb, F., Devlin, J., D, O.G. & Walker, F. (2011). A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis. Int J Rheum Dis, 14(3), 255-260. doi: 10.1111/j.1756-185X.2011.01594.x10.1111/j.1756-185X.2011.01594.x21816021
- 11. Zhang, Q.L. & Rothenbacher, D. (2008). Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health, 8, 117. doi: 10.1186/1471-2458-8-11710.1186/1471-2458-8-117237726018405348
- 12. Hickson, L.J., Crowson, C.S., Gabriel, S.E., McCarthy, J.T. & Matteson, E.L. (2014). Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis, 63(2), 206-213. doi: 10.1053/j.ajkd.2013.08.01010.1053/j.ajkd.2013.08.010394401524100126
- 13. Karstila, K., Korpela, M., Sihvonen, S. & Mustonen, J. (2007). Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study. Clin Rheumatol, 26(12), 2089-2095. doi: 10.1007/s10067-007-0625-y10.1007/s10067-007-0625-y17492249
- 14. Kim, H.W., Lee, C.K., Cha, H.S., Choe, J.Y., Park, E.J. & Kim, J. (2015). Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease. Rheumatol Int, 35(4), 727-734. doi: 10.1007/s00296-014-3146-410.1007/s00296-014-3146-425292347
- 15. Anders, H.J., Rihl, M., Vielhauer, V. & Schattenkirchner, M. (2002). Assessment of renal function in rheumatoid arthritis: validity of a new prediction method. J Clin Rheumatol, 8(3), 130-133.10.1097/00124743-200206000-0000217041340